Niebisch A, Kabus A, Schultz C, Weil B, Bott M: Corynebacterial protein kinase G controls 2-oxoglutarate dehydrogenase activity via the phosphorylation status of the OdhI protein
These medications offer symptomatic relief for motor symptoms
[DOI] [PubMed] [Google Scholar] 28.Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, et al
87 JungW.CastrenE.OdenthalM.Vande WoudeG
Tumours were allowed to develop for 56 weeks until mice showed signs of tumour burden, at which point mice were randomized and treated with a single i.p
The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for DDAVP Nasal Spray and any potential adverse effects on the breastfed infant from DDAVP Nasal Spray or from the underlying maternal condition